Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I read MedCity because it captures the pulse of what's going on in healthcare innovation, a go to source. I also like how MedCity supports women in digital health.”

Dr. Charlene Ngamwajasat, @doctorcharlene, Physician and techie


Sign up for our daily newsletter


Abbott wins FDA approval for heart stent

9:07 am by | 0 Comments

(Reuters) - Abbott Laboratories' Xience Xpedition heart stent was approved by U.S. health regulators and will be launched in the United States immediately, the company said on Thursday.

Heart stents are tiny tubular devices that prop open diseased blood vessels after angioplasty. Abbott's stent delivers a drug, everolimus, which helps keep the vessel from reclogging.

Abbott competes with Medtronic Inc and Boston Scientific in the market for heart stents.

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments